Man Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196K | Buy |
+14,285
| New | +$196K | ﹤0.01% | 1845 |
|
|
2023
Q2 | – | Hold |
0
| – | -$149K | – | 2182 |
|
|
2023
Q1 | – | Sell |
-14,300
| Closed | -$127K | – | 1857 |
|
|
2022
Q4 | $127K | Buy |
+14,300
| New | +$127K | ﹤0.01% | 1866 |
|
|
2019
Q3 | – | Sell |
-16,484
| Closed | -$592K | – | 1909 |
|
|
2019
Q2 | $592K | Sell |
16,484
-162,512
| -91% | -$5.84M | ﹤0.01% | 1632 |
|
|
2019
Q1 | $6.61M | Buy |
178,996
+59,260
| +49% | +$2.19M | 0.03% | 760 |
|
|
2018
Q4 | $5.16M | Buy |
119,736
+13,188
| +12% | +$568K | 0.02% | 746 |
|
|
2018
Q3 | $5.03M | Buy |
106,548
+85,416
| +404% | +$4.03M | 0.02% | 981 |
|
|
2018
Q2 | $1.05M | Buy |
+21,132
| New | +$1.05M | ﹤0.01% | 1582 |
|